ArticleThe Pan African medical journal2026
Extracapillary immunoglobulin A nephropathy glomerulonephritis discovered during the course of pulmonary tuberculosis: a case report.
Article in The Pan African medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Few cases of immunoglobulin A nephropathy (IgAN) associated with tuberculosis have been described in the literature. We report an atypical case of extracapillary IgA glomerulonephritis discovered during the course of pulmonary tuberculosis. The patient, a 45-year-old diagnosed with pulmonary tuberculosis, presented with mixed nephrotic syndrome, characterized by hypertension, hematuria, and acute renal failure. We completed a renal biopsy which showed IgAN with diffuse crescents, classified as (M1E1S1T0C2) according to the Oxford classification. The patient was treated with high-dose of intravenous corticosteroids followed by oral tapering. The antituberculous quadruple therapy was extended to 2.5 months then followed by dual therapy. The course was marked by recovery from pulmonary tuberculosis and a significant improvement in creatinine levels, from 504 µmol/l to 262 µmol/L in five months, but the nephrotic syndrome persisted. In the absence of specific guidelines, this case demonstrates that individualized corticosteroid therapy may be considered in extracapillary IgA glomerulonephritis associated with tuberculosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.